Search Medical Condition
Please enter condition
Please choose location
 

Cardiovascular Abnormalities Clinical Trials

A listing of Cardiovascular Abnormalities medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (29) clinical trials

The study drug reduces CVS events and type 2 Diabetes mellitus in overweight patients

Phase N/A

To collect observational data from real-world use with the Glider PTCA Balloon Catheter to support the effectiveness of the Glider PTCA Balloon for crossing through complex coronary lesions & stent struts

Phase N/A

To evaluate the post-approval data for short and long term performance and clinical outcomes of the Phoenix Atherectomy System. participation is completed after the 12 month post-procedure visit. For pts. without CLI at baseline, participation ends upon completion of the 1 month visit.

Phase N/A

Prospective, consecutively enrolling non-randomized multi center study to evaluate the ultra low profile (14F) Ovation® Abdominal Stent Graft Platform to accommodate small diameter access vessels and challenging aortic necks suggesting this endograft may be particularly well suited to the study of EVAR in women.

Phase N/A

Multi center, non-blinded, non-randomized post approval study looking at the long-term performance of the Relay Thoracic Stent Graft System with Plus Delivery System by assessing the rate of aneurysm-related mortality at 5 years post-implant.

Phase N/A

To evaluate over a 5 year period, the long-term reliability and clinical performance of the ACUITY Spiral lead & evaluate the complication rate associated with the chronic LV lead.

Phase N/A

To test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating AF will be superior to current state-of-the-art medical therapy, with either rate control or rhythm control drugs for reducing total mortality Randomized: 1:1

Phase N/A

Prospective, non-randomized, multi-center, single arm, global IDE clinical study to gather data to satisfy FDA requirements for pre-market submission, on safety, performance and effectiveness of the leads.

Phase N/A

Study Description: To access the battery and device longevity of BSC market-approved ICD and CRT-D devices to validate the device survival information presented in BSC Product Performance Report

Phase N/A

Evaluate whether iv Serelaxin (recombinant for peptide hormone H2 serelaxin, vasodilator) is superior to placebo in: reducing CV death or re-hospitalization due to HF and/or renal failure during a follow up period of 180 days reducing worsening HF & symptoms through Day 5 reducing ICU LOS during index hospitalization

Phase N/A